David P. Hochman - Dec 18, 2024 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role: Chief Executive Officer and Chairperson, Director
Signature: /s/ Andrew Taylor, Attorney-in-Fact
Stock symbol: OBIO
Transactions as of: Dec 18, 2024
Transactions value $: $24,550
Form type: 4
Date filed: 12/19/2024, 08:30 AM
Previous filing: Sep 26, 2024
Next filing: Dec 26, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OBIO	Common Stock, par value $0.0001 per share ("Common Stock")	Purchase	$24.6K	+5K	+0.88%	$4.91	575K	Dec 18, 2024	Direct	F1
holding	OBIO	Common Stock						335K	Dec 18, 2024	By the DPH 2008 Trust
holding	OBIO	Common Stock						2K	Dec 18, 2024	By the Solomon Ascher Hochman 2019 Trust
holding	OBIO	Common Stock						2K	Dec 18, 2024	By the Hannah Hochman 2019 Trust
holding	OBIO	Common Stock						2K	Dec 18, 2024	By the Judah Herman Hochman 2019 Trust
holding	OBIO	Common Stock						3.14K	Dec 18, 2024	By the NSH 2008 Family Trust

Showing 1 to 6 of 6 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.88 to $4.94. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.88 to $4.94. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Remarks:

Chief Executive Officer and Chairperson